Medfødt Naevus -kohort til langsgående evaluering (CIRCLE)
Cirkel: Medfødt Naevus -kohort til langsgående evaluering
Congenital Nevus (CN) is a pigmented skin lesion present at birth, which grows in size as the child grows. It can vary in appearance and is classified by its size, from small (less than 1.5 cm) to giant (greater than 40 cm). CN is associated with genetic mutations, mainly in the NRAS/BRAF genes.
A large CN can lead to several clinical issues, including:
Risk of neurological disorders: Large CN can be associated with neurological abnormalities such as neuro-meningeal melanosis, hydrocephalus, or brain malformations. These conditions may cause early neuro-developmental delays. The risk is not well understood and requires further studies.
Risk of melanoma: The risk of developing melanoma is higher for a large CN but remains low for smaller ones. Increased monitoring is necessary during the early years for large and giant CN.
Psycho-social impact: Parents often experience significant anxiety at birth due to the cancer risk and social stigma. As the child grows, a visible CN may impact their quality of life, particularly socially at school.
Management of CN remains controversial, especially for those of medium to giant size or with multiple satellites. There is an urgent need for further research to clarify best practices in monitoring and treatment, including the need for routine brain imaging and criteria for surgical intervention.
Ultimately, this study aims to deepen our understanding of CN, its associated neurological and melanoma risks, and the psycho-social challenges it poses, while striving to establish clear, evidence-based guidelines for monitoring and treatment to enhance patient outcomes and quality of life.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Research and Innovation Department of Nantes UH
- Telefonnummer: +33253482810
- E-mail: bp-prom-regl@chu-nantes.fr
Undersøgelse Kontakt Backup
- Navn: Hélène AUBERT, M.D.
- E-mail: Helene.AUBERT@chu-nantes.fr
Studiesteder
-
-
-
Lille, Frankrig
- Rekruttering
- CHU Lille
-
Kontakt:
- Olivier PHILIP, MD
- Telefonnummer: +33 320444193
- E-mail: olivier.philip@chu-lille.fr
-
Ledende efterforsker:
- Olivier PHILIP, MD
-
-
Alpes-Maritimes
-
Nice, Alpes-Maritimes, Frankrig, 06130
- Rekruttering
- Grasse Hospital
-
Kontakt:
- Thomas HUBICHE, M.D
- Telefonnummer: +33492037777
- E-mail: hubiche.t@chu-nice.fr
-
Ledende efterforsker:
- Thomas HUBICHE, M.D
-
Nice, Alpes-Maritimes, Frankrig, 06200
- Rekruttering
- Nice University Hospital and Lenval Hospital
-
Kontakt:
- Christine CHIAVERINI, M.D
- Telefonnummer: +33492037777
- E-mail: chiaverini.c@chu-nice.fr
-
Ledende efterforsker:
- Christine CHIAVERINI, M.D
-
-
Bouches-du-Rhône
-
Marseille, Bouches-du-Rhône, Frankrig, 13005
- Rekruttering
- Marseille University Hospital
-
Kontakt:
- Stéphanie MALLET, M.D
- Telefonnummer: +33491380000
- E-mail: Stephanie.mallet@ap-hm.fr
-
Ledende efterforsker:
- Stéphanie MALLET, M.D
-
-
Côte-d'Or
-
Dijon, Côte-d'Or, Frankrig, 21000
- Rekruttering
- Dijon University Hospital
-
Kontakt:
- Bertille BONNIAUD, M.D
- Telefonnummer: +33380293031
- E-mail: bertille.bonniaud@chu-dijon.fr
-
Ledende efterforsker:
- Bertille BONNIAUD, M.D
-
-
Département Et Région d'Outre-mer
-
La Réunion, Département Et Région d'Outre-mer, Frankrig, 97400
- Rekruttering
- La Réunion University Hospital
-
Kontakt:
- Juliette MIQUEL, M.D
- Telefonnummer: +33262359000
- E-mail: Juliette.miquel@chu-reunion.fr
-
Ledende efterforsker:
- Juliette MIQUEL, M.D
-
-
Finistère
-
Brest, Finistère, Frankrig, 29200
- Rekruttering
- Brest University Hospital
-
Kontakt:
- Claire ABASQ, M.D
- Telefonnummer: +33298223315
- E-mail: claire.abasq@chu-brest.fr
-
Ledende efterforsker:
- Claire ABASQ, M.D
-
-
Gironde
-
Bordeaux, Gironde, Frankrig, 33000
- Rekruttering
- Bordeaux University Hospital
-
Kontakt:
- Dorine CANU, M.D
- Telefonnummer: +33557822828
- E-mail: dorine.canu@chu-bordeaux.fr
-
Ledende efterforsker:
- Dorine CANU, M.D
-
-
Haute-Garonne
-
Toulouse, Haute-Garonne, Frankrig, 31300
- Rekruttering
- Toulouse University Hospital
-
Kontakt:
- Maella SEVERINO-FREIRE, M.D
- Telefonnummer: +33567771408
- E-mail: severino-freire.m@chu-toulouse.fr
-
Ledende efterforsker:
- Maella SEVERINO-FREIRE, M.D
-
-
Ille-et-Vilaine
-
Rennes, Ille-et-Vilaine, Frankrig, 35000
- Rekruttering
- Rennes University Hospital
-
Kontakt:
- Catherine DROITCOURT, M.D
- Telefonnummer: +33299284368
- E-mail: Catherine.droitcourt@chu-rennes.fr
-
Ledende efterforsker:
- Catherine DROITCOURT, M.D
-
-
Indre-et-Loire
-
Tours, Indre-et-Loire, Frankrig
- Rekruttering
- Tours University Hospital
-
Kontakt:
- Annabel MARUANI, UH Practitioner
- Telefonnummer: +33663392409
- E-mail: annabel.maruani@univ-tours.fr
-
Ledende efterforsker:
- Annabel MARUANI, UH Practitioner
-
-
Loire Atlantique
-
Nantes, Loire Atlantique, Frankrig, 44300
- Rekruttering
- Nantes University Hospital
-
Kontakt:
- Hélène AUBERT, M.D.
- Telefonnummer: +33240083126
- E-mail: Helene.AUBERT@chu-nantes.fr
-
Ledende efterforsker:
- Hélène AUBERT, M.D.
-
-
Maine et Loire
-
Angers, Maine et Loire, Frankrig, 49100
- Rekruttering
- Angers University Hospital
-
Kontakt:
- Ludovic MARTIN, UH Practitioner
- Telefonnummer: +33241353637
- E-mail: LuMartin@chu-angers.fr
-
Ledende efterforsker:
- Ludovic MARTIN, UH Practitioner
-
-
Meurthe-et-Moselle
-
Nancy, Meurthe-et-Moselle, Frankrig, 54000
- Rekruttering
- Nancy University Hospital
-
Kontakt:
- Anne-Claire BURSZTEJN, M.D
- Telefonnummer: +33383157146
- E-mail: Ac.bursztejn@chru-nancy.fr
-
Ledende efterforsker:
- Anne-Claire BURSZTEJN, M.D
-
-
Nord
-
Lille, Nord, Frankrig, 59000
- Rekruttering
- Saint Vincent de Paul Hospital
-
Kontakt:
- Audrey LASEK, M.D
- Telefonnummer: +33320877576
- E-mail: lasek.audrey@ghicl.net
-
Ledende efterforsker:
- Audrey LASEK, M.D
-
-
Paris
-
Paris, Paris, Frankrig, 75015
- Rekruttering
- Paris Necker Hospital
-
Kontakt:
- Olivia BOCCARA, M.D
- Telefonnummer: +33144494000
- E-mail: olivia.boccara@aphp.fr
-
Ledende efterforsker:
- Olivia BOCCARA, M.D
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patient under 2 years old.
- Patient with a medium, large, or giant congenital nevus (CN) according to the Krengel classification, either single or multiple.
- Patient affiliated with social security.
- Patient whose legal representatives consent to their child's participation in the project.
Exclusion Criteria:
- Patient with light brown spots or pigmented lesions not classified as nevi.
- Patient for whom It is impossible to establish annual follow-up.
- Patient whose parents do not speak French.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Screening
- Tildeling: Ikke-randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Barn med en medfødt nevus
|
This assessment will be conducted using the ASQ-3 test. (ASQ-3 stands for Ages and Stages Questionnaires, Third Edition, which is a common screening tool for evaluating developmental progress in young children.) Collection of patient quality of life data |
|
Andet: Juridiske repræsentanter
|
This meeting will evaluate the parents' acceptance of the lesion and their quality of life using the MARKS test (Measure of Acceptance of Skin Marks). The results will provide insights into how the parents perceive the lesion and how it impacts their daily lives. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Determine the prevalence of neurodevelopmental abnormalities in infants and young children with medium to giant congenital nevus, and according to nevus characteristics (size, number), at the age of 3 years.
Tidsramme: 3 years.
|
This assessment will be conducted using the ASQ-3 (Ages and Stages Questionnaires, Third Edition). |
3 years.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Forekomsten af andre neurologiske abnormiteter (tidlig epilepsi osv.), Screening for psykomotoriske udviklingsforsinkelser.
Tidsramme: 3 år
|
3 år
|
|
|
Forekomsten af neurologiske abnormiteter på MR (magnetisk resonansafbildning), både absolut og i henhold til egenskaberne ved den medfødte nevus.
Tidsramme: 3 år.
|
3 år.
|
|
|
Forekomsten af tidlig melanom eller en anden tumor.
Tidsramme: 3 år.
|
3 år.
|
|
|
Identifikation af faktorer, der påvirker den kliniske plejevej og deres korrelation for sundhedsresultater.
Tidsramme: 3 år.
|
3 år.
|
|
|
The evolution of the clinical characteristics of the congenital nevus (size, color, texture, number of satellites), and associated functional signs (pruritus).
Tidsramme: 3 years.
|
According to the Krengel classification 1 (size, projected adult size, number of satellites) and assessment of color, roughness, hair growth, pruritus/eczematization, and proliferative nodules. |
3 years.
|
|
Description of the histopathological characteristics of the congenital nevus (if available) following excision or biopsy.
Tidsramme: 3 years.
|
If an excision or biopsy is performed, it will be possible to provide the histopathological characteristics of the congenital nevus (CN). |
3 years.
|
|
Description of the molecular characteristics of the congenital nevus (if available) following excision or biopsy.
Tidsramme: 3 years.
|
If an excision or biopsy is performed, it will be possible to provide the molecular characteristics of the congenital nevus (CN). |
3 years.
|
|
Parental satisfaction of cares management and surgery.
Tidsramme: 3 years.
|
Parental satisfaction with the management and surgery, if performed, and evaluation of the patient's satisfaction with the intervention using a Visual Analog Scale (VAS). |
3 years.
|
|
Lesion acceptance and quality of life.
Tidsramme: 3 years.
|
The parents' acceptance of the lesion and their quality of life will be evaluated using the MARKS test (Measure of Acceptance of Skin Marks). The results will provide insights into how the parents perceive the lesion and how it impacts their daily lives. |
3 years.
|
|
Identification of the patient's well-being using the Cartoon CDLQI test.
Tidsramme: 3 years.
|
The Cartoon Children's Dermatology Life Quality Index (Cartoon CDLQI) is a version of the Children's Dermatology Life Quality Index (CDLQI) designed to make assessing the quality of life in children with skin diseases more engaging and accessible for younger children. (Scale from 1 to 4 ; with 4 being the worst outcome ( "a lot" ) and 1 being the best ("not at all"). |
3 years.
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RC24_0532
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .